Enzymatic vitreolysis for the treatment of tractional diabetic macular edema.

Bernardete Pessoa João Coelho Constanca CoelhoSílvia MonteiroCarolina AbreuJoão FigueiraAngelina MeirelesJoão Nuno Melo Beirão

Published in: Therapeutic advances in ophthalmology (2019)

Release of vitreomacular adhesion <2500 μm through enzymatic vitreolysis contributed to the control and stabilization of diabetic macular edema with fewer anti-vascular endothelial growth factor injections, reducing the burden and the risks related to these invasive and frequently chronic treatments.

Keyphrases

vascular endothelial growth factor
hydrogen peroxide
human health
risk factors
risk assessment
platelet rich plasma
nitric oxide
ultrasound guided
climate change
replacement therapy
cystic fibrosis
cell migration
cell adhesion